DNA1-, DNA2-, DNA3-, DNA4-, and DNA6-CAART showed comparable transfection efficacy in T cells from anti-dsDNA+ LN patients (66.0% ± 5.4, 66.0% ± 4.4, 65.1% ± 4.7, 61.6% ± 4.2, 64.6% ± 5.5, respectively, Figure 1B), whereas DNA5-CAART expression was significantly lower (13.5% ± 5.7%, Figure 1B). Here, DNA2 is linked to lobular neoplasia.